#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	528	974	ANT_2____Ia	750	210	98.59	ANT_2____Ia.l15.c30.ctg.1	769	67.9	0	.	p	.	0	F31_V32insG	INS	91	91	T	448	448	T	93	T	91	.	ANT(2'')-Ia;Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	174	CRP	633	633	99.37	CRP.l6.c4.ctg.1	993	9.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	255	257	ACG	11;11;11	A;C;G	11;11;11	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	174	CRP	633	633	99.37	CRP.l6.c4.ctg.1	993	9.2	0	.	p	.	0	T209S	NONSYN	625	627	ACT	795	797	TCT	4;4;4	T;C;T	4;4;4	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	A888G	SNP	888	888	A	13	13	G	1	G	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	C897G	SNP	897	897	C	22	22	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	T898C	SNP	898	898	T	23	23	C	6	C	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	G906T	SNP	906	906	G	31	31	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	G908A	SNP	908	908	G	33	33	A	10	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	A918T	SNP	918	918	A	43	43	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	A943G	SNP	943	943	A	68	68	G	29	G	29	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c4.ctg.2	128	13.5	0	.	n	.	0	G991T	SNP	991	991	G	116	116	T	16	T	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1043	1045	AGC	16;17;17	A,G;G;C	11,5;16;17	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	L121Q	0	.	.	361	363	CTG	224	226	CTG	37;36;37	C;T;G	36;35;36	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Q125R	0	.	.	373	375	CAG	236	238	CAG	34;34;35	C;A;G	34;34;35	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Q125E	0	.	.	373	375	CAG	236	238	CAG	34;34;35	C;A;G	34;34;35	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Q125K	0	.	.	373	375	CAG	236	238	CAG	34;34;35	C;A;G	34;34;35	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Y161D	0	.	.	481	483	TAC	344	346	TAC	45;47;47	T;A;C	45;47;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Y161N	0	.	.	481	483	TAC	344	346	TAC	45;47;47	T;A;C	45;47;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	Y161C	0	.	.	481	483	TAC	344	346	TAC	45;47;47	T;A;C	45;47;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	G317D	0	.	.	949	951	GGC	812	814	GGC	29;29;30	G,T;G;C	28,1;29;30	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	A376S	0	.	.	1126	1128	GCA	989	991	GCA	38;39;37	G;C;A	37;37;37	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	A376V	0	.	.	1126	1128	GCA	989	991	GCA	38;39;37	G;C;A	37;37;37	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	1	SNP	p	E379K	0	.	.	1135	1137	GAA	998	1000	GAA	33;32;32	G;A;A	33;32;32	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	1048	99.43	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1262	30.9	0	HET	.	.	.	C210T	.	210	210	C	73	73	C	21	C,T	13,8	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	185	96.76	Escherichia_coli_EF_Tu.l15.c17.ctg.2	190	7.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	677	858	Escherichia_coli_EF_Tu	1185	188	99.47	Escherichia_coli_EF_Tu.l15.c17.ctg.3	351	10.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	288	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c30.ctg.1	1475	9.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1334	1336	AAA	2;2;1	A;A;A	2;2;1	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	404	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1772	12.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1233	1235	GAA	18;18;18	G;A;A	18;18;18	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	56	H_NS	414	414	99.03	H_NS.l15.c4.ctg.2	419	5.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	14	14	G	58	G	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	15	15	T	60	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1136G	SNP	1136	1136	A	109	109	G	63	G	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1138C	SNP	1138	1138	T	111	111	C	61	C	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1142C	SNP	1142	1142	T	115	115	C	54	C	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1170T	SNP	1170	1170	C	143	143	T	62	T	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1220C	SNP	1220	1220	T	193	193	C	72	C	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1245C	SNP	1245	1245	T	218	218	C	53	C	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1253A	SNP	1253	1253	G	226	226	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1256A	SNP	1256	1256	G	229	229	A	51	A	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1258A	SNP	1258	1258	C	231	231	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1266T	SNP	1266	1266	G	239	239	T	50	T	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1267C	SNP	1267	1267	T	240	240	C	49	C	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1275C	SNP	1275	1275	T	248	248	C	39	C	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1276A	SNP	1276	1276	G	249	249	A	37	A	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1281G	SNP	1281	1281	A	254	254	G	38	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1283C	SNP	1283	1283	T	256	256	C	36	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1288T	SNP	1288	1288	G	261	261	T	39	T	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1296G	SNP	1296	1296	A	269	269	G	53	G	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1299G	SNP	1299	1299	T	272	272	G	60	G	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1300T	SNP	1300	1300	A	273	273	T	60	T	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1356T	SNP	1356	1356	C	329	329	T	70	T	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1358G	SNP	1358	1358	A	331	331	G	69	G	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1368C	SNP	1368	1368	T	341	341	C	67	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1370A	SNP	1370	1370	G	343	343	A	64	A	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1406.	DEL	1406	1406	C	378	378	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	.1409C	INS	1409	1409	T	382	382	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1431A	SNP	1431	1431	C	404	404	A	1	A	1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	C1432A	SNP	1432	1432	C	405	405	A	2	A	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1441G	SNP	1441	1441	A	414	414	G	2	G	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	T1464C	SNP	1464	1464	T	437	437	C	7	C	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	G1473T	SNP	1473	1473	G	446	446	T	23	T	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1475G	SNP	1475	1475	A	448	448	G	30	G	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	.	n	.	0	A1548T	SNP	1548	1548	A	521	521	T	38	T	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	1	SNP	n	C1194G	0	.	.	1194	1194	C	167	167	C	77	C	77	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1166	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l6.c30.ctg.2	564	56.5	0	HET	.	.	.	T1040C	.	1040	1040	T	13	13	T	52	T,C	24,11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	324	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.2	1353	12.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	224	226	CGT	10;9;9	C;G;T	10;9;9	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	324	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.2	1353	12.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1067	1069	GGC	14;15;12	G;G;C	14;15;12	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	410	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1849	11.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	130	132	AGC	8;8;8	A;G;C	8;8;8	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	410	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1849	11.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	532	534	CTA	7;8;8	C;T;A	7;8;8	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	410	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1849	11.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1051	1053	CAA	23;23;21	C;A;A	23;23;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	410	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1849	11.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1150	1152	GGT	12;13;13	G;G;T	12;13;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	410	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1849	11.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1720	1722	GTT	9;8;7	G;T;T	9;8;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	148	PmrE	1167	182	100.0	PmrE.l15.c30.ctg.1	393	5.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	148	PmrE	1167	594	96.3	PmrE.l15.c30.ctg.2	635	4.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	104	106	ACT	5;5;6	A;C;T	5;5;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	148	PmrE	1167	594	96.3	PmrE.l15.c30.ctg.2	635	4.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	494	496	ATC	3;3;3	A;T;C	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	148	PmrE	1167	304	98.36	PmrE.l15.c30.ctg.3	304	7.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	187	189	GAA	6;6;6	G;A;A	6;6;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	16	200	PmrF	969	847	99.41	PmrF.l15.c30.ctg.1	946	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	34	TEM_1+	858	160	98.75	TEM_1+.l15.c30.ctg.1	163	2.3	0	.	p	.	0	M261T	NONSYN	781	783	ATG	105	107	ACG	3;3;3	A;C;G	3;3;3	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	34	TEM_1+	858	180	100.0	TEM_1+.l15.c30.ctg.2	180	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aadA.3002601.NC_010410.3621491_3622283.725	aadA.3002601.NC_010410.3621491_3622283.725	1	0	27	3634	aad-	792	792	100.0	aad-.l15.c30.ctg.1	1422	135.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	716	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3303	11.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	303	305	ATC	8;8;8	A;T;C	8;8;8	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	716	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3303	11.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2016	2018	AAG	6;6;6	A;A;G	6;6;6	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	531	330	acrE	1158	1092	98.81	acrE.l15.c30.ctg.1	1152	14.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	739	741	TGC	23;23;21	T;G;C	23;23;21	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	2380	98.82	acrF.l15.c4.ctg.1	2428	14.1	0	.	p	.	0	M421V	NONSYN	1261	1263	ATG	536	538	GTG	16;15;14	G;T;G	16;15;14	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	2380	98.82	acrF.l15.c4.ctg.1	2428	14.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1070	1072	AAT	15;15;15	A;A;T	15;15;15	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	2380	98.82	acrF.l15.c4.ctg.1	2428	14.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1184	1186	AGT	9;8;9	A;G;T	9;8;9	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	2380	98.82	acrF.l15.c4.ctg.1	2428	14.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	1583	1585	GTG	18;18;17	G;T;G	18;18;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	2380	98.82	acrF.l15.c4.ctg.1	2428	14.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2138	2140	AAG	14;14;15	A;A;G	14;13;15	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	738	98.51	acrF.l15.c4.ctg.2	944	10.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	342	342	T	12	T	12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	738	98.51	acrF.l15.c4.ctg.2	944	10.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	648	650	GAC	19;19;18	G;A;C	18;19;18	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	834	acrF	3105	738	98.51	acrF.l15.c4.ctg.2	944	10.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	924	926	TTA	3;3;3	T;T;A	3;3;3	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	148	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	915	8.1	1	SNP	p	R45C	0	.	.	133	135	CGC	382	384	CGC	9;9;9	C;G;C	9;8;9	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	166	acrS	663	663	98.79	acrS.l15.c30.ctg.1	869	10.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	116	118	TTC	6;5;5	T;T;C	6;5;5	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	166	acrS	663	663	98.79	acrS.l15.c30.ctg.1	869	10.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	380	382	GGG	8;8;8	G;G;G	8;8;8	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	216	adiY	762	762	99.61	adiY.l6.c4.ctg.1	1130	10.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	595	597	CTT	14;15;14	C;T;T	14;15;14	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	788	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3024	14.0	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2040	2042	GCA	14;14;13	G;C;A	14;14;13	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	788	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3024	14.0	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2301	2303	ACC	17;16;16	A;C;C	17;16;16	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	788	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3024	14.0	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2610	2612	GCC	11;11;12	G;C;C	11;11;12	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	1545	98.45	arnA_1.l6.c4.ctg.1	1648	9.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	116	118	TGC	5;5;5	T;G;C	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	1545	98.45	arnA_1.l6.c4.ctg.1	1648	9.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	299	301	GTT	9;9;9	G;T;T	9;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	1545	98.45	arnA_1.l6.c4.ctg.1	1648	9.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	449	451	CAC	12;12;13	C;A;C	12;12;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	1545	98.45	arnA_1.l6.c4.ctg.1	1648	9.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	734	736	ATG	8;9;9	A;T;G	8;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	156	98.72	arnA_1.l6.c4.ctg.2	156	7.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	57	59	CGC	6;7;9	C;G;C	6;7;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	350	arnA_1	1983	118	97.46	arnA_1.l6.c4.ctg.3	120	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	513	164	bacA	822	692	98.41	bacA.l6.c4.ctg.1	798	8.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	618	620	ACC	4;4;4	A;C;C	4;4;4	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	513	164	bacA	822	692	98.41	bacA.l6.c4.ctg.1	798	8.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	630	632	TCG	7;7;8	T;C;G	6;6;8	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	513	164	bacA	822	129	99.22	bacA.l6.c4.ctg.2	165	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	124	baeR	723	145	98.62	baeR.l15.c4.ctg.1	145	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	124	baeR	723	516	97.67	baeR.l15.c4.ctg.2	739	7.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	160	95.62	baeS.l15.c4.ctg.1	160	5.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	10	12	AAA	2;2;2	A;A;A	2;2;2	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	160	95.62	baeS.l15.c4.ctg.1	160	5.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	22	24	GAG	2;2;3	G;A;G	2;2;3	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	160	95.62	baeS.l15.c4.ctg.1	160	5.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	28	30	CAC	3;3;3	C;A;C	3;3;3	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	160	95.62	baeS.l15.c4.ctg.1	160	5.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	82	84	GAG	10;10;10	G;A;G	10;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	1093	99.27	baeS.l15.c4.ctg.2	1156	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	250	baeS	1404	93	98.92	baeS.l15.c4.ctg.3	98	4.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
catI.3002683.V00622.243_903.482	catI.3002683.V00622.243_903.482	1	0	27	246	cat+	660	660	99.85	cat+.l15.c4.ctg.1	1066	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	catI;catI is a chromosome and transposon-encoded variant of the cat gene found in Escherichia coli and Acinetobacter baumannii
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	442	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1445	15.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	258	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1037	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	196	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1235	8.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	1	0	27	1424	dfhr3b	480	480	100.0	dfhr3b.l15.c4.ctg.1	941	80.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: AY162283.2 Citrobacter freundii transposon class I integron In38 IntI1 integron integrase (intI1) gene, partial cds, aminoglycoside (6') N-acetyltransferase AAC(6')-II (aacA4), beta-lactamase OXA-4 (bla(OXA-4)), quaternary ammonium compound resistance protein (qacEdelta1), dihydropteroate synthase (sul1), Orf513 (orf513), dihydrofolate reductase type IIIb (dfrA3b), and Orf105 (orf105) genes, complete cds, qacEdelta1 pseudogene, complete sequence, and dihydropteroate synthase (sul1) gene, partial cds
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	310	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1557	10.6	0	.	p	.	0	W42C	NONSYN	124	126	TGG	306	308	TGT	8;7;7	T;G;T	8;7;7	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	310	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1557	10.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	837	839	GTC	7;7;7	G;T;C	7;7;7	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	448	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	1901	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	390	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1368	14.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	800	802	AGC	5;6;6	A;G;C	5;6;6	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	216	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1455	7.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	711	713	AGG	9;9;9	A;G;G	9;9;9	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	216	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1455	7.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1101	1103	GAC	5;5;6	G;A;C	5;5;6	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	178	emrR	531	531	100.0	emrR.l15.c4.ctg.1	926	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	1	318	emrY	1539	1334	99.78	emrY.l15.c4.ctg.1	1516	9.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	1	318	emrY	1539	215	100.0	emrY.l15.c4.ctg.2	450	7.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	130	evgA	615	615	99.19	evgA.l6.c30.ctg.1	861	7.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	269	271	CTG	14;14;15	C;T;G	14;14;15	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	174	176	ATA	5;5;5	A;T;A	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	186	188	GTA	4;6;6	G;T;A	4;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	339	341	ACG	7;7;7	A;C;G	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	402	404	GAA	6;7;7	G;A;A	6;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	441	443	GCT	10;11;11	G;C;T	10;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	459	461	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	546	548	TCA	7;7;5	T;C;A	7;7;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	619	96.93	evgS.l15.c4.ctg.1	681	8.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	675	677	CAG	1;1;1	C;A;G	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	1158	96.55	evgS.l15.c4.ctg.2	1169	7.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	3;4;4	A;A;A	3;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	1158	96.55	evgS.l15.c4.ctg.2	1169	7.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	932	934	CAT	9;9;9	C;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	1158	96.55	evgS.l15.c4.ctg.2	1169	7.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	986	988	CAT	3;3;3	C;A;T	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	1158	96.55	evgS.l15.c4.ctg.2	1169	7.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1004	1006	AGA	6;6;6	A;G;A	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	1158	96.55	evgS.l15.c4.ctg.2	1169	7.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1019	1021	AAT	6;6;6	A;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	108	98.15	evgS.l15.c4.ctg.3	108	5.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	95	97	GAT	1;1;1	G;A;T	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	905	99.45	evgS.l15.c4.ctg.4	997	9.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	162	164	CAC	5;5;5	C;A;C	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	905	99.45	evgS.l15.c4.ctg.4	997	9.5	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	900	902	AAC	4;4;4	A;A;C	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	178	96.63	evgS.l15.c4.ctg.5	178	5.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	8	10	CAG	1;1;1	C;A;G	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	178	96.63	evgS.l15.c4.ctg.5	178	5.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	146	148	GTT	4;3;3	G;T;T	4;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	433	98.15	evgS.l15.c4.ctg.6	433	8.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	9	11	TCC	3;3;3	T;C;C	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	433	98.15	evgS.l15.c4.ctg.6	433	8.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	174	176	ATT	5;6;5	A;T;T	5;6;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	433	98.15	evgS.l15.c4.ctg.6	433	8.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	195	197	GAT	11;11;10	G;A;T	11;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	433	98.15	evgS.l15.c4.ctg.6	433	8.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	309	311	GTT	9;9;9	G;T;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	562	evgS	3594	181	95.58	evgS.l15.c4.ctg.7	182	5.0	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	169	171	AAT	2;2;2	A;A;T	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	224	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1219	9.9	1	SNP	p	P64L	0	.	.	190	192	CCA	389	391	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	224	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1219	9.9	1	SNP	p	P64R	0	.	.	190	192	CCA	389	391	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	224	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1219	9.9	1	SNP	p	P64S	0	.	.	190	192	CCA	389	391	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	224	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1219	9.9	1	SNP	p	P64H	0	.	.	190	192	CCA	389	391	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	224	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1219	9.9	1	SNP	p	P64A	0	.	.	190	192	CCA	389	391	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	128	gadE	528	528	100.0	gadE.l15.c4.ctg.2	784	8.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	44	gadW	729	142	97.18	gadW.l15.c4.ctg.1	142	6.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	44	gadW	729	139	95.68	gadW.l15.c4.ctg.2	139	3.9	0	.	p	.	0	K110N	NONSYN	328	330	AAA	11	13	AAT	3;3;3	A;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	150	gadX	825	825	97.94	gadX.l6.c4.ctg.1	919	7.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	189	191	TTA	8;9;9	T;T;A	8;9;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	150	gadX	825	825	97.94	gadX.l6.c4.ctg.1	919	7.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	267	269	ATT	5;5;5	A;T;T	5;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	150	gadX	825	825	97.94	gadX.l6.c4.ctg.1	919	7.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	768	770	GGA	4;4;4	G;G;A	4;4;4	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	150	gadX	825	825	97.94	gadX.l6.c4.ctg.1	919	7.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	774	776	CCG	3;3;2	C;C;G	3;3;2	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2211	2213	GAA	7;7;6	G;A;A	7;6;6	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	S83L	0	.	.	247	249	TCG	426	428	TCG	14;14;14	T;C;G	14;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	S83I	0	.	.	247	249	TCG	426	428	TCG	14;14;14	T;C;G	14;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	S83W	0	.	.	247	249	TCG	426	428	TCG	14;14;14	T;C;G	14;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	D87N	0	.	.	259	261	GAC	438	440	GAC	14;14;13	G;A;C	13;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	D87G	0	.	.	259	261	GAC	438	440	GAC	14;14;13	G;A;C	13;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	D87H	0	.	.	259	261	GAC	438	440	GAC	14;14;13	G;A;C	13;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	438	440	GAC	14;14;13	G;A;C	13;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	624	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3004	11.1	1	SNP	p	D87V	0	.	.	259	261	GAC	438	440	GAC	14;14;13	G;A;C	13;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136C	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136L	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136S	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136H	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136I	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136G	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	704	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2713	13.6	1	SNP	p	R136E	0	.	.	406	408	CGC	664	666	CGC	14;14;14	C;G;C	14;14;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	146	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	840	8.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	298	300	CCG	17;17;17	C;C;G	17;17;17	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	146	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	840	8.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	451	453	GCC	6;5;5	G;C;C	6;5;5	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	264	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1301	10.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	236	238	TCA	11;10;10	T;C;A	11;10;10	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	72	marA	384	384	99.74	marA.l15.c30.ctg.1	730	5.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	331	333	AGC	2;1;1	A;G;C	2;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	V45E	0	.	.	133	135	GTG	157	159	GTG	3;3;3	G;T;G	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	I49S	0	.	.	145	147	ATC	169	171	ATC	4;4;4	A;T;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	A70T	0	.	.	208	210	GCA	232	234	GCA	7;7;7	G;C;A	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R73S	0	.	.	217	219	CGT	241	243	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R73C	0	.	.	217	219	CGT	241	243	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R77L	0	.	.	229	231	CGC	253	255	CGC	8;8;7	C;G;C	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R77C	0	.	.	229	231	CGC	253	255	CGC	8;8;7	C;G;C	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	L78M	0	.	.	232	234	CTG	256	258	CTG	6;6;6	C;T;G	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R94S	0	.	.	280	282	CGC	304	306	CGC	1;1;1	C;G;C	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	R94H	0	.	.	280	282	CGC	304	306	CGC	1;1;1	C;G;C	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	52	marR	435	395	97.97	marR.l6.c4.ctg.1	420	4.6	1	SNP	p	V96E	0	.	.	286	288	GTA	310	312	GTA	1;1;1	G;T;A	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	158	mdfA	1233	1018	97.64	mdfA.l15.c4.ctg.2	1033	7.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	128	130	CAG	6;6;6	C;A;G	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	158	mdfA	1233	1018	97.64	mdfA.l15.c4.ctg.2	1033	7.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	167	169	GCC	7;7;7	G;C;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	158	mdfA	1233	1018	97.64	mdfA.l15.c4.ctg.2	1033	7.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	272	274	GCG	5;5;4	G;C;G	5;5;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	158	mdfA	1233	1018	97.64	mdfA.l15.c4.ctg.2	1033	7.2	0	.	p	.	0	L231V	NONSYN	691	693	CTT	476	478	GTT	6;6;6	G;T;T	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	528	158	mdfA	1233	1018	97.64	mdfA.l15.c4.ctg.2	1033	7.2	0	.	p	.	0	R285fs	FSHIFT	853	853	C	638	638	C	6	C	6	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	760	98.29	mdtA.l15.c30.ctg.1	882	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	277	96.03	mdtA.l15.c30.ctg.2	292	5.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	55	55	G	9	G	9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	277	96.03	mdtA.l15.c30.ctg.2	292	5.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	112	114	CAG	5;6;6	C;A;G	5;6;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	277	96.03	mdtA.l15.c30.ctg.2	292	5.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	262	264	ATC	3;3;3	A;T;C	3;3;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	157	98.09	mdtA.l15.c30.ctg.4	157	4.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	27	29	ATG	1;1;1	A;T;G	1;1;1	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	204	mdtA	1248	157	98.09	mdtA.l15.c30.ctg.4	157	4.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	120	122	ACC	3;3;3	A;C;C	3;3;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	N134T	NONSYN	400	402	AAC	7	9	ACC	1;1;1	A;C;C	0;0;0	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1354	1356	ACC	14;15;14	A;C;C	14;15;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	1747	1749	CAA	9;9;9	C;A;A	9;9;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	1915	1917	ATT	5;5;5	A;T;T	5;5;5	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	1999	2001	GTT	13;13;13	G;T;T	13;13;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2107	2109	GAG	6;5;5	G;A;G	6;5;5	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2335	2337	ATG	6;6;6	A;T;G	6;6;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	2730	98.83	mdtB.l6.c30.ctg.1	2830	10.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	2470	2472	GAT	9;9;9	G;A;T	9;9;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	513	656	mdtB	3123	413	99.52	mdtB.l6.c30.ctg.2	413	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	638	mdtC	3078	2998	98.7	mdtC.l6.c4.ctg.1	3018	10.9	0	.	p	.	0	I46M	NONSYN	136	138	ATC	56	58	ATG	10;10;10	A;T;G	10;10;10	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	638	mdtC	3078	2998	98.7	mdtC.l6.c4.ctg.1	3018	10.9	0	.	p	.	0	V208I	NONSYN	622	624	GTC	542	544	ATC	12;12;12	A;T;C	12;12;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	638	mdtC	3078	2998	98.7	mdtC.l6.c4.ctg.1	3018	10.9	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2858	2860	CAC	3;3;3	C;A;C	3;3;3	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	346	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1576	11.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	150	152	GAA	10;9;9	G;A;A	9;9;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	346	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1576	11.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	819	821	GCG	10;10;10	G;C;G	9;10;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	346	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1576	11.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1161	1163	ATC	10;10;10	A;T;C	9;10;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	346	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1576	11.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1464	1466	TTT	15;15;14	T;T;T	15;15;14	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	368	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1543	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	878	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3534	13.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1106	1108	ACC	10;10;10	A;C;C	10;10;10	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	878	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3534	13.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2348	2350	GAC	14;13;13	G;A;C	14;13;13	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	264	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1286	8.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	466	468	ATC	11;11;11	A;T;C	11;11;11	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	264	mdtG	1227	170	99.41	mdtG.l15.c30.ctg.2	170	6.9	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	2;3;3	G;G;A	2;3;3	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	216	mdtH	1209	1197	98.25	mdtH.l6.c4.ctg.1	1207	9.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	388	390	TGT	14;14;14	T;G;T	14;14;14	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	216	mdtH	1209	1197	98.25	mdtH.l6.c4.ctg.1	1207	9.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	958	960	TTG	8;9;11	T;T;G	8;9;11	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	216	mdtH	1209	1197	98.25	mdtH.l6.c4.ctg.1	1207	9.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1168	1170	ACG	3;3;3	A;C;G	3;3;3	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	318	mdtL	1176	1176	98.21	mdtL.l15.c30.ctg.1	1377	11.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	698	700	TCC	12;12;12	T;C;C,A	12;12;11,1	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	252	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1261	10.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	531	533	ATT	10;11;11	A;T;T	10;11;11	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	V11M	NONSYN	31	33	GTG	144	146	ATG	10;10;10	A;T;G	9;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	T33I	NONSYN	97	99	ACC	210	212	ATC	7;7;7	A;T;C	7;7;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	C116R	NONSYN	346	348	TGC	459	461	CGC	15;14;14	C;G;C	14;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	N238S	NONSYN	712	714	AAC	825	827	AGC	6;6;7	A;G;C	6;6;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1026	1028	GTG	11;10;10	G;T;G	11;9;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1089	1091	AAC	9;9;9	A;A;C	9;7;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	500	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2204	11.3	0	.	p	.	0	P330fs	FSHIFT	988	988	C	1101	1101	C	13	C	13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	564	98.23	mdtP.l15.c17.ctg.1	669	9.9	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	307	307	T	7	T	6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	564	98.23	mdtP.l15.c17.ctg.1	669	9.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	490	492	GCG	8;8;8	G;C;G	8;8;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	564	98.23	mdtP.l15.c17.ctg.1	669	9.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	664	666	ACC	2;2;2	A;C;C	2;2;2	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	66	68	CGC	10;9;10	C;G;C	10;9;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	183	185	GCT	8;10;11	G;C;T	8;10;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	267	269	AAA	9;9;9	A;A;A	9;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	285	287	CGA	10;10;10	C;G;A	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	450	452	GCC	13;13;13	G;C;C	13;13;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	462	464	GAT	11;10;10	G;A;T	11;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	513	302	mdtP	1467	902	97.67	mdtP.l15.c17.ctg.2	927	9.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	879	881	GCT	4;4;4	G;C;T	4;4;4	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	790	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3739	11.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1562	1564	AAG	13;13;13	A;A;G	13;12;13	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	790	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3739	11.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2639	2641	CTG	17;17;17	C;T;G	17;16;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	40	mgrB	144	138	100.0	mgrB.l15.c30.ctg.2	155	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	424	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	1963	11.5	0	.	p	.	0	S278N	NONSYN	832	834	AGC	953	955	AAC	7;7;7	A;A;C	7;7;7	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	424	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	1963	11.5	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1499	1501	ATA	20;20;20	A;T;A	20;20;20	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	378	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.2	1444	13.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1150	1152	GAT	21;21;21	G;A;T	21;21;21	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	378	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.2	1444	13.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1153	1155	CTG	20;22;22	C;T;G	20;22;22	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	313	99.04	nfsA.l6.c4.ctg.1	526	7.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	265	267	TGT	10;10;10	T;G;T	10;10;10	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	313	99.04	nfsA.l6.c4.ctg.1	526	7.0	1	SNP	p	R15C	0	.	.	43	45	CGC	229	231	CGC	15;14;14	C;G;C	15;14;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	313	99.04	nfsA.l6.c4.ctg.1	526	7.0	1	SNP	p	S33R	0	.	.	97	99	AGC	283	285	AGC	9;9;9	A;G;C	9;9;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	419	99.05	nfsA.l6.c4.ctg.2	757	6.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	238	240	ACC	8;8;8	A;C;C	8;8;8	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	419	99.05	nfsA.l6.c4.ctg.2	757	6.2	0	.	p	.	0	G187D	NONSYN	559	561	GGC	448	450	GAC	5;6;6	G;A;C	5;6;6	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	419	99.05	nfsA.l6.c4.ctg.2	757	6.2	1	SNP	p	G131D	0	.	.	391	393	GGC	280	282	GGC	9;8;8	G;G;C	9;8;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	419	99.05	nfsA.l6.c4.ctg.2	757	6.2	1	SNP	p	R203L	0	.	.	607	609	CGT	496	498	CGT	9;9;10	C;G;T	9;9;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	164	nfsA	723	419	99.05	nfsA.l6.c4.ctg.2	757	6.2	1	SNP	p	R203C	0	.	.	607	609	CGT	496	498	CGT	9;9;10	C;G;T	9;9;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	312	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1176	13.5	0	.	p	.	0	D312E	NONSYN	934	936	GAT	959	961	GAG	16;16;16	G;A;G	16;16;16	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	312	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1176	13.5	1	SNP	p	G141D	0	.	.	421	423	GGT	446	448	GGT	11;11;11	G;G;T	11;11;11	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	312	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1176	13.5	1	SNP	p	G141E	0	.	.	421	423	GGT	446	448	GGT	11;11;11	G;G;T	11;11;11	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	312	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1176	13.5	1	SNP	p	R154A	0	.	.	460	462	CGT	485	487	CGT	11;11;11	C;G;T	11;11;10	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	312	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1176	13.5	1	SNP	p	R154D	0	.	.	460	462	CGT	485	487	CGT	11;11;11	C;G;T	11;11;10	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	686	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2527	14.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1727	1729	TCG	19;19;20	T;C;G	18;18;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	686	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2527	14.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2342	2344	AAC	7;7;7	A;A;C	7;7;7	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	686	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2527	14.3	1	SNP	p	A85T	0	.	.	253	255	GCG	356	358	GCG	13;13;13	G;C;G	12;12;12	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	686	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2527	14.3	1	SNP	p	D111H	0	.	.	331	333	GAT	434	436	GAT	21;21;22	G;A;T	21;21;22	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	686	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2527	14.3	1	SNP	p	S129P	0	.	.	385	387	TCC	488	490	TCC	11;11;10	T;C;C	11;11;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	410	parE_1	1893	978	97.96	parE_1.l6.c4.ctg.1	1026	12.3	0	.	p	.	0	Q377trunc	TRUNC	1129	1129	C	219	219	T	2	T,C	0,1	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	410	parE_1	1893	978	97.96	parE_1.l6.c4.ctg.1	1026	12.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	516	518	GAT	16;16;16	G;A;T	16;15;15	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	410	parE_1	1893	630	97.62	parE_1.l6.c4.ctg.2	660	8.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	410	parE_1	1893	257	97.28	parE_1.l6.c4.ctg.4	261	6.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	386	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1806	11.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1284	1286	GAT	16;17;18	G;A;T	16;17;17	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	V146F	0	.	.	436	438	GTT	623	625	GTT	20;20;20	G;T;T	20;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1724	1726	CAG	19;19;19	C;A;G	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1724	1726	CAG	19;19;19	C;A;G	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1763	1765	CAC	15;15;15	C;A;C	15;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1772	1774	CGT	14;14;14	C;G;T	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1772	1774	CGT	14;14;14	C;G;T	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1778	1780	TCC	12;12;12	T;C;C	12;12;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1784	1786	CTC	12;13;13	C;T;C	12;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1874	1876	ACC	16;17;17	A;C;C	16;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1877	1879	CCT	16;16;17	C;C;T	16;16;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1342	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4426	16.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2246	2248	CGT	19;19;19	C;G;T	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	.	n	.	0	A226G	SNP	226	226	A	324	324	G	111	G	110	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	1100	1100	A	36	A,G	28,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	1	SNP	n	A794T	0	.	.	794	794	A	892	892	A	89	A	89	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	1	SNP	n	A794G	0	.	.	794	794	A	892	892	A	89	A	89	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	1	SNP	n	G926A	0	.	.	926	926	G	1024	1024	G	84	G	83	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	1	SNP	n	G926C	0	.	.	926	926	G	1024	1024	G	84	G	83	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	1	SNP	n	G926T	0	.	.	926	926	G	1024	1024	G	84	G	83	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	C194T	.	194	194	C	292	292	C	86	C,T	74,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	T90C	.	90	90	T	188	188	T	95	T,C	60,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	A79G	.	79	79	A	177	177	A	92	A,G	57,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	T273A	.	273	273	T	371	371	T	91	T,A	53,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	C183T	.	183	183	C	281	281	C	75	C,T	48,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	G474A	.	474	474	G	572	572	G	114	G,A	92,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	A250T	.	250	250	A	348	348	A	100	A,T	62,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	1005	99.8	rrsB+.l15.c30.ctg.2	1103	92.0	0	HET	.	.	.	A253T	.	253	253	A	351	351	A	103	A,T	66,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	114.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	72	A	72	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	114.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	72	A	72	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	114.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	72	A	72	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	50	50	A	39	A,G	38,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	54	54	C	46	C,G	45,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	58	58	C	44	C,T	43,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	66	66	G	39	G	39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	.1023G	INS	1023	1023	T	71	71	G	39	G	38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	138	94.96	rrsB+.l15.c30.ctg.5	138	24.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	86	86	T	38	T	37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3374	rrsB+	1542	137	99.27	rrsB+.l15.c30.ctg.6	137	18.1	0	.	n	.	0	G1002A	SNP	1002	1002	G	49	49	A	32	A,G	0,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	168	soxR	465	465	100.0	soxR.l15.c4.ctg.1	647	13.6	1	SNP	p	R20H	0	.	.	58	60	CGC	216	218	CGC	13;14;15	C;G;C	12;14;14	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	168	soxR	465	465	100.0	soxR.l15.c4.ctg.1	647	13.6	1	SNP	p	G121D	0	.	.	361	363	GGT	519	521	GGT	15;15;15	G;G;T	15;15;15	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	110	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	727	8.1	1	SNP	p	A12S	0	.	.	34	36	GCA	246	248	GCA	16;16;15	G;C;A	16;16;15	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul1.manually_added_NC_002134_NP_052895.3_12192_13058	sul1.manually_added_NC_002134_NP_052895.3_12192_13058	1	0	59	5042	sul1	867	867	100.0	sul1.l15.c17.ctg.2	1060	229.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	426	tet-	1206	1206	99.92	tet-.l15.c30.ctg.1	1449	15.3	0	.	p	.	0	S137I	NONSYN	409	411	AGT	625	627	ATT	11;12;12	A;T;T	11;12;12	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	154	tetC	594	594	99.66	tetC.l6.c4.ctg.1	960	8.5	0	.	p	.	0	S152D	NONSYN	454	456	AGT	632	634	GAT	8;10;10	G;A;T	8;10;10	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	186	tetD	417	417	100.0	tetD.l15.c4.ctg.1	806	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.;tetD
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	280	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1012	14.6	1	SNP	p	H64Y	0	.	.	190	192	CAC	381	383	CAC	21;21;21	C;A;C	21;21;21	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	280	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1012	14.6	1	SNP	p	N82H	0	.	.	244	246	AAT	435	437	AAT	16;17;17	A;A;T	16;17;17	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	280	tetR_1	624	624	100.0	tetR_1.l15.c4.ctg.1	1012	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	539	422	tolC	1488	1488	98.66	tolC.l6.c30.ctg.1	1948	11.7	0	.	p	.	0	S92F	NONSYN	274	276	TCC	527	529	TTC	23;23;23	T;T;C	23;23;23	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
